The Bottom Line GLP-1 fatigue is real, common, and rarely talked about in detail unless youre the one collapsing into bed at four in the afternoon
Injecting contaminated semaglutide raises the risk of injection-site infection, cellulitis, or abscess formation
Surveillance should comprise routine clinical and specific reproductive-related laboratory monitoring, with defined strategies for treatment cessation if issues emerge
"I hope that I don't have to do that, but I'm not embarrassed to if it's necessary." In this installment of On My Weigh , Carter-Williams explains in her own words how taking a GLP-1 helped her turn her health around and learn that "to truly love yourself is to take care of yourself inside and out." The weigh-in Name: ShantaQuilette Carter-Williams Age: 47 The method: Ozempic, 12.5 milligrams from February 2022 until October 2023, then Mounjaro, 15 milligrams until weaning off of GLP-1s in February 2025 The goal: I had had a heart attack and stroke, and I was diagnosed with type 2 diabetes, as well as being obese
